The American Journal of Gastroenterology 110, 444-454 (March 2015) | doi:10.1038/ajg.2015.6 TAKE-HOME MESSAGE In this meta-analysis, researchers evaluated the diagnostic potential of biomarkers for irritable bowel disease (IBD) and irritable bowel syndrome (IBS), finding that biomarkers did not differentiate patients with IBS from controls. The risk for IBD was ≤1% with C-reactive protein ≤0.5 and […]